comparemela.com

Latest Breaking News On - Patient positioning system - Page 4 : comparemela.com

Alphatec Holdings, Inc (NASDAQ:ATEC) EVP Sells $37,500 00 in Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) EVP David Sponsel sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $15.00, for a total value of $37,500.00. Following the sale, the executive vice president now directly owns 557,780 shares […]

Brokerages Set Alphatec Holdings, Inc (NASDAQ:ATEC) Target Price at $22 14

Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) have received an average rating of “Buy” from the seven research firms that are covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued a report on the […]

Needham & Company LLC Raises Alphatec (NASDAQ:ATEC) Price Target to $18 00

Alphatec (NASDAQ:ATEC – Free Report) had its target price increased by Needham & Company LLC from $16.00 to $18.00 in a report issued on Tuesday, MarketBeat.com reports. The firm currently has a buy rating on the medical technology company’s stock. A number of other research analysts have also recently weighed in on ATEC. StockNews.com began […]

Alphatec Holdings, Inc (NASDAQ:ATEC) Short Interest Down 6 6% in November

Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) was the target of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 10,960,000 shares, a decline of 6.6% from the November 15th total of 11,740,000 shares. Based on an average daily volume of 2,010,000 shares, […]

Alphatec Holdings, Inc (NASDAQ:ATEC) Receives $21 86 Consensus Target Price from Analysts

Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) has been assigned an average rating of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued ratings on the stock in […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.